Unilever faces mounting investor backlash over bid for GSK consumer health unit News07trends


Source: universalpersonality.com universalpersonality.com

Key Topics in this News Article:

News Snapshot:

Unilever faces rising investor backlash towards GSK’s £ 50 billion bid for consumer health as inventory costs fall to their lowest ranges in practically 5 years. Considered one of Unilever’s high 20 shareholders informed the Monetary Instances: “Unilever’s administration has rather a lot to show,” mentioned high 15 traders to point out traders that the proposed acquisition is “not an indication of despair.” Related Articles KPMG partner said he was unaware of alleged forgery of Carillion audit documents 1 hour ago António Horta-Osório resigns as Credit Suisse chair over Covid breaches 4 hours ago “I want lots of convincing about...